STOCK TITAN

MEDICAL CARE TECHS (MDCE) Stock Price, News & Analysis

MDCE OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
62 245 sessions, September 25, 2025 to September 25, 2026
Largest daily move
+100% close of March 25, 2026
1-year change
-66.7% closing prices, September 25, 2025 to September 25, 2026
5-year change
-99.5% closing prices, September 24, 2021 to September 25, 2026

Company Description

Medical Care Technologies Inc. (OTC Pink: MDCE) is described in company communications as a technology-focused business developing AI-driven consumer, wellness, and medical applications, while also operating wholly owned subsidiaries in the sports memorabilia and collectibles market. According to recent updates, the company is advancing a portfolio of AI-powered mobile applications alongside its subsidiaries Infinite Auctions LLC and Real Game Used LLC (RGU).

Core business focus

Medical Care Technologies states that it develops AI-based mobile applications across lifestyle, wellness, nutrition insight, and medical pre-screening categories. Company press releases describe an expanding pipeline that includes consumer-focused AI apps in the food and nutrition space, lifestyle and wellness tools, and a mobile application for skin lesion pre-screening and risk-awareness. These applications use AI-driven visual analysis and pattern observation to support user awareness and engagement in health and wellness, while emphasizing that such tools are educational and not diagnostic.

The company also highlights plans to launch its first consumer-based AI mobile application across a large number of countries and languages, with the goal of establishing its first direct, non-subsidiary revenue stream from consumer AI applications. Corporate communications describe short-term, near-term, and long-term goals that include consumer app launches, development of medical-grade beta applications, and exploration of clinical and institutional pathways for medical-focused technologies.

AI-powered consumer and health applications

Medical Care Technologies reports that its first international AI-based mobile application in the food and nutrition sector has been approved for launch and distribution on the iOS App Store. The company describes this app as using AI imaging analysis tools to generate recipes based on photos of ingredients, with planned distribution across many countries and language localizations. Management commentary positions this application as the company’s initial entry into the global consumer AI market and as a foundation for future AI-driven health, wellness, and medical pre-screening applications.

Another key project described by the company is an AI-powered mobile application for skin lesion pre-screening. According to press materials, this app uses AI-driven visual analysis to help users observe characteristics such as asymmetry, border irregularity, color variation, surface changes, and general visual anomalies that may warrant clinical attention. The company emphasizes that this tool is intended for education and awareness, does not provide medical advice, and encourages users to seek evaluation from qualified clinicians when atypical features are identified.

Subsidiaries: Infinite Auctions and Real Game Used (RGU)

Medical Care Technologies states that it owns two subsidiaries that operate in the sports memorabilia and collectibles space:

  • Infinite Auctions – A subsidiary that conducts auctions of high-value collectibles and artwork. Company news highlights events such as "The Legends Art Auction," featuring original artwork by Rob Prior and pieces associated with figures such as Stan Lee, Chris Evans, Al Pacino, Peyton Manning, and Canelo Alvarez. Corporate communications describe Infinite Auctions as contributing to the strength and growth of Medical Care Technologies’ overall portfolio through premium, high-value items.
  • Real Game Used (RGU) – A subsidiary focused on the authentication, photo-matching, valuation, and sale of significant game-used sports memorabilia. RGU is described as using a patent-pending AI analysis and search platform to evaluate visual pattern similarity, mesh-hole alignment, letter and number spacing, stitching characteristics, wear patterns, fabric anomalies, and logo and numeral placement relative to photographic sources. Company updates describe RGU as a trusted resource for advanced collectors and established auction house clients.

Corporate releases describe synergies between RGU and Infinite Auctions, where RGU’s AI-based photo-matching capabilities help identify rare, high-value memorabilia that Infinite Auctions then authenticates and offers to the market. The company states that this collaboration is intended to support long-term funding for technology development and to strengthen the financial foundation for its AI application roadmap.

AI strategy and development roadmap

Medical Care Technologies outlines a multi-stage strategy for its AI initiatives. Short-term plans described in shareholder updates include launching its first completed consumer AI mobile application, announcing the official branding of that app, and outlining additional AI applications across health, wellness, and dietary categories. The company also refers to ongoing development and testing of AI-based mobile applications addressing consumer and medical needs, including projects in prototype stages.

Near-term goals communicated by the company include developing and releasing one or more medical-grade beta applications, conducting structured beta testing with medical student groups, and advancing select applications into clinical-grade efficacy testing supervised by medical professionals. Long-term goals discussed in corporate communications include seeking an uplisting to OTCQB subject to qualification standards, completing a provisional patent related to a patent-pending AI analysis process, exploring clinical and institutional partnerships, and evaluating regulatory pathways for medical-grade AI applications where applicable.

Use of AI and technology positioning

Across multiple press releases, Medical Care Technologies emphasizes the role of agentic AI, trained AI models, and AI-driven imaging and pattern analysis in both its consumer applications and its memorabilia-focused subsidiaries. The company states that advancements in AI have allowed it to accelerate development timelines and broaden the scope of its smart device application portfolio. Attendance at technology events such as CES is described as a way for the company’s leadership and technical team to engage with developments in artificial intelligence, mobile technologies, and robotics, and to inform its AI wellness application portfolio.

Business segments

Based on company communications, Medical Care Technologies’ activities can be viewed in two main areas:

  • AI consumer and health applications – Development of AI-driven mobile applications in food and nutrition, lifestyle, wellness, and medical pre-screening, with an emphasis on scalable international distribution and multi-language support.
  • Sports memorabilia and collectibles – Operation of Infinite Auctions and Real Game Used, which focus on high-value collectibles, game-used sports memorabilia, and AI-based authentication and photo-matching technologies.

The company states that revenue from its subsidiaries and from AI-identified memorabilia acquisitions is expected to support ongoing technology development and marketing for its AI application portfolio.

Status and trading

Company press releases identify Medical Care Technologies Inc. as trading on the OTC Pink market under the symbol MDCE. Recent communications present the company as active in both AI application development and memorabilia-related operations. No SEC filings are provided in the available data, and no delisting, merger, or bankruptcy events are described in the supplied materials.

FAQs about Medical Care Technologies Inc. (MDCE)

Stock Performance

$0.0001
+0.00%
+0.00
Last updated: September 25, 2026 at 15:24
-66.7%
Performance 1 year
$325.0K

MEDICAL CARE TECHS (MDCE) closed at $0.0001 on September 25, 2026. Over the past 12 months, the price has lost 66.7%.

See what a $1,000 investment in MDCE would be worth today

MDCE Metrics & Rankings

Price returns through September 25, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

MEDICAL CARE TECHS has 10 recent news articles, with the latest published 3 days ago. Of the recent coverage, 2 articles coincided with positive price movement and 1 with negative movement. Key topics include AI. View all MDCE news →

SEC Filings

MEDICAL CARE TECHS has filed 2 recent SEC filings, including 1 Form 1-A/A, 1 Form 1-A. The most recent filing was submitted on June 22, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all MDCE SEC filings →

Financial Highlights

net income was -$1.9M. The company generated -$372K in operating cash flow. With a current ratio of 0.09, short-term liquidity bears monitoring.

-$1.9M
Net Income (FY2011)
-$372K
Operating Cash Flow
—
Revenue (FY2011)

Upcoming Events

JAN
01
January 1, 2027 - December 31, 2029 Clinical

Medical-grade development

Roadmap sets 2027+ medical ambitions including medical-grade beta apps and provisional patent advancement; see corporate website.
JAN
01
January 1, 2027 Corporate

Pursue OTCQB uplisting

Company intends to pursue an OTCQB uplisting starting 2027+ if qualified
JAN
01
January 1, 2027 Corporate

Complete provisional patent

Complete provisional patent for AI image analysis (targeted 2027+)
JAN
01
January 1, 2027 Corporate

Evaluate separate subsidiary tickers

Assess separate tickers for subsidiaries once sustained revenue is achieved (2027+)
JAN
01
January 1, 2027 - April 30, 2027 Product

Multiple AI app launches

Multiple AI app launches planned in early 2027; announced Apr 9, 2026; aiming to expand user acquisition

MEDICAL CARE TECHS has 5 upcoming scheduled events. The next event, "Medical-grade development", is scheduled for January 1, 2027 (in 95 days). Investors can track these dates to stay informed about potential catalysts that may affect the MDCE stock price.

Short Interest History

Last 12 Months

Short interest in MEDICAL CARE TECHS (MDCE) currently stands at 1.5 million shares, representing 0.0% of the shares outstanding. Since September 2025, short interest has increased by 11.4%.

Days to Cover History

Last 12 Months

Days to cover for MEDICAL CARE TECHS (MDCE) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.

MDCE Company Profile & Sector Positioning

MEDICAL CARE TECHS (MDCE) operates in the Internet Retail industry within the broader Consumer Cyclical sector and is listed on the OTC.

Investors comparing MDCE often look at related companies in the same sector, including YUKA GROUP INC (YUKA), JIVA TECHNOLOGIES INC (PLTXF), KIDPIK CORP (PIKM), BRAVADA INTL LTD (BRAV), and BTAB ECOMMERCE GROUP INC (BBTT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MDCE's relative position within its industry.

Frequently Asked Questions

What is the current stock price of MEDICAL CARE TECHS (MDCE)?

The current stock price of MEDICAL CARE TECHS (MDCE) is $0.0001 as of September 25, 2026.

What is the market cap of MEDICAL CARE TECHS (MDCE)?

The market cap of MEDICAL CARE TECHS (MDCE) is approximately $325.0K. Learn more about what market capitalization means .

What is the net income of MEDICAL CARE TECHS (MDCE)?

The FY2011 net income of MEDICAL CARE TECHS (MDCE) is -$1.9M, from its most recent completed fiscal year.

What is the operating cash flow of MEDICAL CARE TECHS (MDCE)?

The operating cash flow of MEDICAL CARE TECHS (MDCE) is -$372K. Learn about cash flow.

What is the current ratio of MEDICAL CARE TECHS (MDCE)?

The current ratio of MEDICAL CARE TECHS (MDCE) is 0.09, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What does Medical Care Technologies Inc. (MDCE) do?

According to its press releases, Medical Care Technologies Inc. develops AI-driven consumer, wellness, and medical applications while also operating wholly owned subsidiaries in the sports memorabilia and collectibles market, including Infinite Auctions and Real Game Used.

How does MDCE use artificial intelligence in its business?

Company communications describe AI as central to MDCE’s strategy. Its mobile applications use AI-driven imaging and pattern analysis for areas such as food and nutrition and skin lesion pre-screening, while its Real Game Used subsidiary uses a patent-pending AI analysis platform for authenticating and photo-matching game-used sports memorabilia.

What are MDCE’s main AI mobile application projects?

Press releases highlight an AI-based food and nutrition app that generates recipes from photos of ingredients, as well as an AI-powered skin lesion pre-screening and risk-awareness app. The company also references additional lifestyle, wellness, dietary, and medical pre-screening applications in development.

What is Infinite Auctions and what role does it play for MDCE?

Infinite Auctions is a subsidiary of Medical Care Technologies that conducts auctions of high-value collectibles and artwork. Company news describes events such as "The Legends Art Auction" and notes that Infinite Auctions contributes to MDCE’s overall portfolio through premium, high-value items.

How are Real Game Used and Infinite Auctions connected?

Corporate updates describe a collaboration where Real Game Used uses its AI technology to identify rare, photo-matched memorabilia, and Infinite Auctions authenticates and acquires these items for sale. MDCE states that this synergy is intended to support long-term funding for its technology development.

Does MDCE generate revenue only from its subsidiaries?

MDCE’s communications indicate that its subsidiaries Infinite Auctions and Real Game Used generate revenue through high-value collectible sales and AI-based authentication services. The company also states that its first consumer AI application is expected to represent its first source of revenue generated outside of its subsidiaries.

What are MDCE’s stated short-term and long-term goals?

In its shareholder update, MDCE lists short-term goals such as launching its first consumer-based AI mobile application and outlining additional AI apps across health, wellness, and dietary categories. Near-term goals include developing medical-grade beta applications and conducting structured beta testing, while long-term goals include pursuing an uplisting to OTCQB, completing a provisional patent related to its AI analysis process, and exploring clinical and institutional partnerships.

Is MDCE focused only on consumer apps or also on medical technologies?

MDCE describes a dual focus. It is developing consumer-facing AI applications in areas like food, nutrition, lifestyle, and wellness, and it is also working on medical pre-screening and medical-grade applications, with plans for beta testing and potential clinical-grade efficacy testing under medical supervision.

On which market does MDCE trade and under what symbol?

Company press releases identify Medical Care Technologies Inc. as trading on the OTC Pink market under the ticker symbol MDCE.